BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

OrthoAccel® Technologies, Inc. Receives Clearance From Korean Food and Drug Administration for AcceleDent™


9/26/2012 9:39:33 AM

HOUSTON, Sept. 26, 2012 /PRNewswire/ -- OrthoAccel Technologies has just received official clearance from the Korean Food and Drug Administration (KFDA) to begin commercial sales of its AcceleDent orthodontic device in South Korea.

"I'm extremely gratified by this news," says Mr. Sung-ku Hong, CEO of Inno DMC, the exclusive South Korean distributor. "AcceleDent is an important advancement in orthodontic care and I'm certain it will be welcomed by Korean orthodontists and their patients."

Michael K. Lowe, CEO of OrthoAccel® Technologies, adds, "We've been eager to open the South Korean market since first entering into a distribution agreement with Inno DMC back in 2010. This is an exciting step, marking the company's first movement into the Asia Pacific region."

AcceleDent is a lightweight, hands-free appliance used at home to speed up the rate of orthodontic treatment. It's used 20 minutes a day by biting gently on the mouthpiece to hold it in place. Patients are then free to engage in normal activities, like reading, texting, or watching TV, during the treatment. Sales of AcceleDent have increased rapidly since it received FDA clearance in November, 2011.

The addition of the South Korean market continues a trend that has seen OrthoAccel® expand into over 20 international markets as well as the United States.

About OrthoAccel® Technologies, Inc.

Based in Houston, Texas, OrthoAccel® Technologies, Inc. is a privately owned medical device company currently engaged in the development, manufacturing, and marketing of products to enhance dental care and orthodontic treatment.

OrthoAccel® developed and sells AcceleDent, the first FDA-cleared clinical approach to safely accelerate orthodontic tooth movement by applying gentle vibrations, micropulses, as a complement to existing orthodontic treatment. More information can be found at www.acceledent.com and www.acceledent.co.uk or requested via info@orthoaccel.com.

SOURCE OrthoAccel Technologies, Inc.



Read at BioSpace.com

 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES